Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Turcot syndrome × IMM-101 × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2 Turcot syndrome 1 Pancreatic Neoplasms 1 Melanoma 1 Advanced Pancreatic Cancer 1

Interventions

Nivolumab 5 pembrolizumab 3 Neoadjuvant Therapy 3 durvalumab 2 avelumab 2 atezolizumab 2 toripalimab 1 spartalizumab 1 relatlimab 1 fludarabine phosphate 1 fludarabine 1 dostarlimab 1 danvatirsen 1 Surgical Procedures, Operative 1 Oxaliplatin 1 Leucovorin 1 Ipilimumab 1 Induction Chemotherapy 1 Immunotherapy 1 Immunoglobulin G 1 Immune Checkpoint Inhibitors 1 IMM-101 1 Fluorouracil 1 Docetaxel 1 Disulfides 1 DEAE-Dextran 1 Cyclophosphamide 1 Chemotherapy, Adjuvant 1 Celecoxib 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05118724 2025-06-15

ANTONIO

AIO-Studien-gGmbH

Phase 2 Active not recruiting

Gastrointestinal

Turcot syndrome, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡